Korea Q4 Roundup: Overseas Sales, M&A Provide Growth Amid General Weakness

Hanmi Dispute Finally Ends

 
• By Jung Won Shin
  
weak earnings
Majority Of Korean Pharma Report Weak Q4 Earnings

More from South Korea

More from Business